EUVIMEDEUVIMED entdecken
Crossref

Prognostic Evaluation of Decompensated Chronic Liver Disease: A Comparison Between CHIBA and MELD Scores

Kiran Raj

Journal of MedVerse Research & Practice · 2025

DOI: 10.65188/nurexus.1021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of MedVerse Research & Practice, 2025. Verfasst von Kiran Raj. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Decompensated chronic liver disease (DCLD) represents an advanced stage of liver dysfunction characterized by complications such as jaundice, ascites, hepatic encephalopathy, and variceal bleeding. These manifestations indicate a significant decline in liver function and contribute to increased mortality rates globally. Materials and Methods: A hospital-based observational cohort study was carried out at Government Medical College Hospital, Kannyakumari. The study involved 50 patients diagnosed with DCLD. Data were systematically collected, recorded in Microsoft Excel, and analyzed using IBM SPSS Statistics version 27.

Results

Out of the 50 patients enrolled, 89% had a history of alcohol consumption, while 11% were smokers. The mean Model for End-Stage Liver Disease (MELD) score was 22.0 ± 2.56, indicating a moderate degree of liver dysfunction with minimal variability. In contrast, the mean CHIBA score was 12.9 ± 7.89, reflecting a broader range of values. Statistical analysis revealed that both scoring systems were significant predictors (p < 0.001).

Conclusion

The CHIBA score demonstrated greater prognostic value compared to the MELD score in assessing outcomes in patients with decompensated chronic liver disease. However, further multicentric studies and prospective validations are necessary to confirm its clinical applicability. Keywords: CHIBA score, MELD score, Decompensated Chronic Liver Disease, Prognosis, Liver Dysfunction

Zitieren

APA

Raj, K. (2025). Prognostic Evaluation of Decompensated Chronic Liver Disease: A Comparison Between CHIBA and MELD Scores. Journal of MedVerse Research & Practice. https://doi.org/10.65188/nurexus.1021

Vancouver

Raj K. Prognostic Evaluation of Decompensated Chronic Liver Disease: A Comparison Between CHIBA and MELD Scores. Journal of MedVerse Research & Practice. 2025. doi:10.65188/nurexus.1021

BibTeX
@article{Raj2025,
  author = {Raj, Kiran},
  title = {Prognostic Evaluation of Decompensated Chronic Liver Disease: A Comparison Between CHIBA and MELD Scores},
  journal = {Journal of MedVerse Research & Practice},
  year = {2025},
  doi = {10.65188/nurexus.1021}
}
Kostenlos starten →